Ownership

David Apelian - Insider Trading & Ownership

Entity: Individual
Location: C/O Achillion Pharmaceuticals, Inc, 300 George Street, New Haven, CT
Summary: The estimated net worth of David Apelian is at least $3.28K dollars as of July 6, 2023. David Apelian is the CEO, Director of Eiger BioPharmaceuticals, Inc. and owns shares of Eiger BioPharmaceuticals, Inc. (EIGRQ) stock worth about $3.28K.
All Insider Reports: All Insider Reports

Ownership of David Apelian

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
EIGRQ	Eiger BioPharmaceuticals, Inc.	CEO, Director	$3.28K			Jul 3, 2023

Insider Transactions Reported by David Apelian:

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.